Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Sell
49
RSPH Quote, Financials, Valuation and Earnings
Last price:
$32.11
Seasonality move
:
2.75%
Day range:
$32.01 - $32.16
52-week range:
$26.36 - $32.62
Dividend yield:
0.7%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
--
Volume:
38.4K
Avg. volume:
66.2K
1-year change:
8.47%
Market cap:
--
Revenue:
--
EPS (TTM):
--
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
RSPH
Invesco S&P 500 Eql Wght Health Care ETF
|
-- | -- | -- | -- | -- |
|
FBT
First Trust NYSE Arca Biotechnology Index Fund
|
-- | -- | -- | -- | -- |
|
PBE
Invesco Biotechnology & Genome ETF
|
-- | -- | -- | -- | -- |
|
PJP
Invesco Pharmaceuticals ETF
|
-- | -- | -- | -- | -- |
|
XBI
State Street SPDR S&P Biotech ETF
|
-- | -- | -- | -- | -- |
|
XLV
State Street Health Care Select Sector SPDR ETF
|
-- | -- | -- | -- | -- |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
RSPH
Invesco S&P 500 Eql Wght Health Care ETF
|
$32.13 | -- | -- | -- | $0.05 | 0.7% | -- |
|
FBT
First Trust NYSE Arca Biotechnology Index Fund
|
$215.07 | -- | -- | -- | $1.17 | 0% | -- |
|
PBE
Invesco Biotechnology & Genome ETF
|
$84.16 | -- | -- | -- | $0.42 | 0.97% | -- |
|
PJP
Invesco Pharmaceuticals ETF
|
$108.08 | -- | -- | -- | $0.25 | 0.95% | -- |
|
XBI
State Street SPDR S&P Biotech ETF
|
$126.30 | -- | -- | -- | $0.41 | 0.35% | -- |
|
XLV
State Street Health Care Select Sector SPDR ETF
|
$155.80 | -- | -- | -- | $0.66 | 1.59% | -- |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
RSPH
Invesco S&P 500 Eql Wght Health Care ETF
|
-- | 0.671 | -- | -- |
|
FBT
First Trust NYSE Arca Biotechnology Index Fund
|
-- | 0.657 | -- | -- |
|
PBE
Invesco Biotechnology & Genome ETF
|
-- | 0.859 | -- | -- |
|
PJP
Invesco Pharmaceuticals ETF
|
-- | 0.316 | -- | -- |
|
XBI
State Street SPDR S&P Biotech ETF
|
-- | 1.273 | -- | -- |
|
XLV
State Street Health Care Select Sector SPDR ETF
|
-- | 0.326 | -- | -- |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
RSPH
Invesco S&P 500 Eql Wght Health Care ETF
|
-- | -- | -- | -- | -- | -- |
|
FBT
First Trust NYSE Arca Biotechnology Index Fund
|
-- | -- | -- | -- | -- | -- |
|
PBE
Invesco Biotechnology & Genome ETF
|
-- | -- | -- | -- | -- | -- |
|
PJP
Invesco Pharmaceuticals ETF
|
-- | -- | -- | -- | -- | -- |
|
XBI
State Street SPDR S&P Biotech ETF
|
-- | -- | -- | -- | -- | -- |
|
XLV
State Street Health Care Select Sector SPDR ETF
|
-- | -- | -- | -- | -- | -- |
Invesco S&P 500 Eql Wght Health Care ETF vs. Competitors
-
Which has Higher Returns RSPH or FBT?
First Trust NYSE Arca Biotechnology Index Fund has a net margin of -- compared to Invesco S&P 500 Eql Wght Health Care ETF's net margin of --. Invesco S&P 500 Eql Wght Health Care ETF's return on equity of -- beat First Trust NYSE Arca Biotechnology Index Fund's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital RSPHInvesco S&P 500 Eql Wght Health Care ETF-- -- -- FBTFirst Trust NYSE Arca Biotechnology Index Fund-- -- -- -
What do Analysts Say About RSPH or FBT?
Invesco S&P 500 Eql Wght Health Care ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand First Trust NYSE Arca Biotechnology Index Fund has an analysts' consensus of -- which suggests that it could fall by --. Given that Invesco S&P 500 Eql Wght Health Care ETF has higher upside potential than First Trust NYSE Arca Biotechnology Index Fund, analysts believe Invesco S&P 500 Eql Wght Health Care ETF is more attractive than First Trust NYSE Arca Biotechnology Index Fund.
Company Buy Ratings Hold Ratings Sell Ratings RSPHInvesco S&P 500 Eql Wght Health Care ETF0 0 0 FBTFirst Trust NYSE Arca Biotechnology Index Fund0 0 0 -
Is RSPH or FBT More Risky?
Invesco S&P 500 Eql Wght Health Care ETF has a beta of 0.923, which suggesting that the stock is 7.663% less volatile than S&P 500. In comparison First Trust NYSE Arca Biotechnology Index Fund has a beta of 0.724, suggesting its less volatile than the S&P 500 by 27.562%.
-
Which is a Better Dividend Stock RSPH or FBT?
Invesco S&P 500 Eql Wght Health Care ETF has a quarterly dividend of $0.05 per share corresponding to a yield of 0.7%. First Trust NYSE Arca Biotechnology Index Fund offers a yield of 0% to investors and pays a quarterly dividend of $1.17 per share. Invesco S&P 500 Eql Wght Health Care ETF pays -- of its earnings as a dividend. First Trust NYSE Arca Biotechnology Index Fund pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios RSPH or FBT?
Invesco S&P 500 Eql Wght Health Care ETF quarterly revenues are --, which are smaller than First Trust NYSE Arca Biotechnology Index Fund quarterly revenues of --. Invesco S&P 500 Eql Wght Health Care ETF's net income of -- is lower than First Trust NYSE Arca Biotechnology Index Fund's net income of --. Notably, Invesco S&P 500 Eql Wght Health Care ETF's price-to-earnings ratio is -- while First Trust NYSE Arca Biotechnology Index Fund's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Invesco S&P 500 Eql Wght Health Care ETF is -- versus -- for First Trust NYSE Arca Biotechnology Index Fund. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income RSPHInvesco S&P 500 Eql Wght Health Care ETF-- -- -- -- FBTFirst Trust NYSE Arca Biotechnology Index Fund-- -- -- --
-
Which has Higher Returns RSPH or PBE?
Invesco Biotechnology & Genome ETF has a net margin of -- compared to Invesco S&P 500 Eql Wght Health Care ETF's net margin of --. Invesco S&P 500 Eql Wght Health Care ETF's return on equity of -- beat Invesco Biotechnology & Genome ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital RSPHInvesco S&P 500 Eql Wght Health Care ETF-- -- -- PBEInvesco Biotechnology & Genome ETF-- -- -- -
What do Analysts Say About RSPH or PBE?
Invesco S&P 500 Eql Wght Health Care ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand Invesco Biotechnology & Genome ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that Invesco S&P 500 Eql Wght Health Care ETF has higher upside potential than Invesco Biotechnology & Genome ETF, analysts believe Invesco S&P 500 Eql Wght Health Care ETF is more attractive than Invesco Biotechnology & Genome ETF.
Company Buy Ratings Hold Ratings Sell Ratings RSPHInvesco S&P 500 Eql Wght Health Care ETF0 0 0 PBEInvesco Biotechnology & Genome ETF0 0 0 -
Is RSPH or PBE More Risky?
Invesco S&P 500 Eql Wght Health Care ETF has a beta of 0.923, which suggesting that the stock is 7.663% less volatile than S&P 500. In comparison Invesco Biotechnology & Genome ETF has a beta of 0.822, suggesting its less volatile than the S&P 500 by 17.787%.
-
Which is a Better Dividend Stock RSPH or PBE?
Invesco S&P 500 Eql Wght Health Care ETF has a quarterly dividend of $0.05 per share corresponding to a yield of 0.7%. Invesco Biotechnology & Genome ETF offers a yield of 0.97% to investors and pays a quarterly dividend of $0.42 per share. Invesco S&P 500 Eql Wght Health Care ETF pays -- of its earnings as a dividend. Invesco Biotechnology & Genome ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios RSPH or PBE?
Invesco S&P 500 Eql Wght Health Care ETF quarterly revenues are --, which are smaller than Invesco Biotechnology & Genome ETF quarterly revenues of --. Invesco S&P 500 Eql Wght Health Care ETF's net income of -- is lower than Invesco Biotechnology & Genome ETF's net income of --. Notably, Invesco S&P 500 Eql Wght Health Care ETF's price-to-earnings ratio is -- while Invesco Biotechnology & Genome ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Invesco S&P 500 Eql Wght Health Care ETF is -- versus -- for Invesco Biotechnology & Genome ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income RSPHInvesco S&P 500 Eql Wght Health Care ETF-- -- -- -- PBEInvesco Biotechnology & Genome ETF-- -- -- --
-
Which has Higher Returns RSPH or PJP?
Invesco Pharmaceuticals ETF has a net margin of -- compared to Invesco S&P 500 Eql Wght Health Care ETF's net margin of --. Invesco S&P 500 Eql Wght Health Care ETF's return on equity of -- beat Invesco Pharmaceuticals ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital RSPHInvesco S&P 500 Eql Wght Health Care ETF-- -- -- PJPInvesco Pharmaceuticals ETF-- -- -- -
What do Analysts Say About RSPH or PJP?
Invesco S&P 500 Eql Wght Health Care ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand Invesco Pharmaceuticals ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that Invesco S&P 500 Eql Wght Health Care ETF has higher upside potential than Invesco Pharmaceuticals ETF, analysts believe Invesco S&P 500 Eql Wght Health Care ETF is more attractive than Invesco Pharmaceuticals ETF.
Company Buy Ratings Hold Ratings Sell Ratings RSPHInvesco S&P 500 Eql Wght Health Care ETF0 0 0 PJPInvesco Pharmaceuticals ETF0 0 0 -
Is RSPH or PJP More Risky?
Invesco S&P 500 Eql Wght Health Care ETF has a beta of 0.923, which suggesting that the stock is 7.663% less volatile than S&P 500. In comparison Invesco Pharmaceuticals ETF has a beta of 0.506, suggesting its less volatile than the S&P 500 by 49.387%.
-
Which is a Better Dividend Stock RSPH or PJP?
Invesco S&P 500 Eql Wght Health Care ETF has a quarterly dividend of $0.05 per share corresponding to a yield of 0.7%. Invesco Pharmaceuticals ETF offers a yield of 0.95% to investors and pays a quarterly dividend of $0.25 per share. Invesco S&P 500 Eql Wght Health Care ETF pays -- of its earnings as a dividend. Invesco Pharmaceuticals ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios RSPH or PJP?
Invesco S&P 500 Eql Wght Health Care ETF quarterly revenues are --, which are smaller than Invesco Pharmaceuticals ETF quarterly revenues of --. Invesco S&P 500 Eql Wght Health Care ETF's net income of -- is lower than Invesco Pharmaceuticals ETF's net income of --. Notably, Invesco S&P 500 Eql Wght Health Care ETF's price-to-earnings ratio is -- while Invesco Pharmaceuticals ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Invesco S&P 500 Eql Wght Health Care ETF is -- versus -- for Invesco Pharmaceuticals ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income RSPHInvesco S&P 500 Eql Wght Health Care ETF-- -- -- -- PJPInvesco Pharmaceuticals ETF-- -- -- --
-
Which has Higher Returns RSPH or XBI?
State Street SPDR S&P Biotech ETF has a net margin of -- compared to Invesco S&P 500 Eql Wght Health Care ETF's net margin of --. Invesco S&P 500 Eql Wght Health Care ETF's return on equity of -- beat State Street SPDR S&P Biotech ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital RSPHInvesco S&P 500 Eql Wght Health Care ETF-- -- -- XBIState Street SPDR S&P Biotech ETF-- -- -- -
What do Analysts Say About RSPH or XBI?
Invesco S&P 500 Eql Wght Health Care ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand State Street SPDR S&P Biotech ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that Invesco S&P 500 Eql Wght Health Care ETF has higher upside potential than State Street SPDR S&P Biotech ETF, analysts believe Invesco S&P 500 Eql Wght Health Care ETF is more attractive than State Street SPDR S&P Biotech ETF.
Company Buy Ratings Hold Ratings Sell Ratings RSPHInvesco S&P 500 Eql Wght Health Care ETF0 0 0 XBIState Street SPDR S&P Biotech ETF0 0 0 -
Is RSPH or XBI More Risky?
Invesco S&P 500 Eql Wght Health Care ETF has a beta of 0.923, which suggesting that the stock is 7.663% less volatile than S&P 500. In comparison State Street SPDR S&P Biotech ETF has a beta of 0.931, suggesting its less volatile than the S&P 500 by 6.918%.
-
Which is a Better Dividend Stock RSPH or XBI?
Invesco S&P 500 Eql Wght Health Care ETF has a quarterly dividend of $0.05 per share corresponding to a yield of 0.7%. State Street SPDR S&P Biotech ETF offers a yield of 0.35% to investors and pays a quarterly dividend of $0.41 per share. Invesco S&P 500 Eql Wght Health Care ETF pays -- of its earnings as a dividend. State Street SPDR S&P Biotech ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios RSPH or XBI?
Invesco S&P 500 Eql Wght Health Care ETF quarterly revenues are --, which are smaller than State Street SPDR S&P Biotech ETF quarterly revenues of --. Invesco S&P 500 Eql Wght Health Care ETF's net income of -- is lower than State Street SPDR S&P Biotech ETF's net income of --. Notably, Invesco S&P 500 Eql Wght Health Care ETF's price-to-earnings ratio is -- while State Street SPDR S&P Biotech ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Invesco S&P 500 Eql Wght Health Care ETF is -- versus -- for State Street SPDR S&P Biotech ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income RSPHInvesco S&P 500 Eql Wght Health Care ETF-- -- -- -- XBIState Street SPDR S&P Biotech ETF-- -- -- --
-
Which has Higher Returns RSPH or XLV?
State Street Health Care Select Sector SPDR ETF has a net margin of -- compared to Invesco S&P 500 Eql Wght Health Care ETF's net margin of --. Invesco S&P 500 Eql Wght Health Care ETF's return on equity of -- beat State Street Health Care Select Sector SPDR ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital RSPHInvesco S&P 500 Eql Wght Health Care ETF-- -- -- XLVState Street Health Care Select Sector SPDR ETF-- -- -- -
What do Analysts Say About RSPH or XLV?
Invesco S&P 500 Eql Wght Health Care ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand State Street Health Care Select Sector SPDR ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that Invesco S&P 500 Eql Wght Health Care ETF has higher upside potential than State Street Health Care Select Sector SPDR ETF, analysts believe Invesco S&P 500 Eql Wght Health Care ETF is more attractive than State Street Health Care Select Sector SPDR ETF.
Company Buy Ratings Hold Ratings Sell Ratings RSPHInvesco S&P 500 Eql Wght Health Care ETF0 0 0 XLVState Street Health Care Select Sector SPDR ETF0 0 0 -
Is RSPH or XLV More Risky?
Invesco S&P 500 Eql Wght Health Care ETF has a beta of 0.923, which suggesting that the stock is 7.663% less volatile than S&P 500. In comparison State Street Health Care Select Sector SPDR ETF has a beta of 0.656, suggesting its less volatile than the S&P 500 by 34.433%.
-
Which is a Better Dividend Stock RSPH or XLV?
Invesco S&P 500 Eql Wght Health Care ETF has a quarterly dividend of $0.05 per share corresponding to a yield of 0.7%. State Street Health Care Select Sector SPDR ETF offers a yield of 1.59% to investors and pays a quarterly dividend of $0.66 per share. Invesco S&P 500 Eql Wght Health Care ETF pays -- of its earnings as a dividend. State Street Health Care Select Sector SPDR ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios RSPH or XLV?
Invesco S&P 500 Eql Wght Health Care ETF quarterly revenues are --, which are smaller than State Street Health Care Select Sector SPDR ETF quarterly revenues of --. Invesco S&P 500 Eql Wght Health Care ETF's net income of -- is lower than State Street Health Care Select Sector SPDR ETF's net income of --. Notably, Invesco S&P 500 Eql Wght Health Care ETF's price-to-earnings ratio is -- while State Street Health Care Select Sector SPDR ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Invesco S&P 500 Eql Wght Health Care ETF is -- versus -- for State Street Health Care Select Sector SPDR ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income RSPHInvesco S&P 500 Eql Wght Health Care ETF-- -- -- -- XLVState Street Health Care Select Sector SPDR ETF-- -- -- --
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is SentinelOne Stock Undervalued?
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Is Broadcom Stock on Sale?
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Stock Ideas
Buy
57
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 64x
Buy
55
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 37x
Buy
61
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 39x
Alerts
Buy
80
TVTX alert for Dec 25
Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.
Buy
68
KOD alert for Dec 25
Kodiak Sciences, Inc. [KOD] is up 13.41% over the past day.
Buy
64
ZCSH alert for Dec 25
Grayscale Zcash Trust (ZEC) [ZCSH] is up 5.33% over the past day.
